1315 Capital /
Argonaut's Life Sciences and Diagnostics division (now Aluris Sciences)
1315 Capital completed the acquisition of Argonaut Manufacturing Services' Life Sciences and Diagnostics division on Sep 9, with the unit now operating independently as Aluris Sciences.
The transaction, in context.
Terms were undisclosed. Argonaut remains with Telegraph Hill Partners, New Vale Capital, and management. [01]
Aluris is a Carlsbad CDMO for life sciences, diagnostics, and combination drug products spanning formulation, filling, kitting, lyophilization, assembly, and packaging. Stacy Sutton runs it as COO. Rick Hancock stays CEO of Argonaut's aseptic fill-finish core. [01]
The people. The paper.
The stills posted with the deal, in post order. The @carrywatch post is the basis for this record.
1315 Capital completed the acquisition of Argonaut Manufacturing Services' Life Sciences and Diagnostics division on Sep 9, with the unit now operating independently as Aluris Sciences.
Supports the named parties, stage and people shown on this page.
Open the post on XWhere the record stands.
Closed, as posted
1315 Capital acquired Argonaut's Life Sciences and Diagnostics division (now Aluris Sciences) from Argonaut Manufacturing Services (Closed, posted 13 Sep 2026).
Source 01
Follow the relationship.
The buyer, target and seller named in the post. Each connection returns to the same source.
Argonaut's Life Sciences and Diagnostics division (now Aluris Sciences)
The company the post describes as the subject of the deal.
Select an entity or relationship to see what the post says about it.
Rick Hancock
CEO, Argonaut Manufacturing Services